Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Tongue Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Non-Muscle Invasive Bladder Neoplasms 1Lymphoid Interstitial Pneumonia 1Keratosis, Actinic 1Esophageal Squamous Cell Carcinoma 1Epitheliod Malignant Pleural Mesothelioma 1Carcinoma, Transitional Cell 1Carcinoma, Basal Cell 1

Interventions

Platinum 2Gemcitabine 2Gefitinib 2Cisplatin 2Cetuximab 21,2-diaminocyclohexaneplatinum II citrate 2vandetanib 1temsirolimus 1linrodostat 1ficlatuzumab 1durvalumab 1cediranib 1adavosertib 1Trioxsalen 1Soybean Proteins 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Phototherapy 1Photochemotherapy 1Pemetrexed 1Paclitaxel 1Nivolumab 1Immunohistochemistry 1Dihematoporphyrin Ether 1Carboplatin 1Biopsy 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphoid Interstitial Pneumonia × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT02068157 2017-10-11

Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer

Roswell Park Cancer Institute

Phase 2 Terminated
3 enrolled 8 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡